PF-07038124 or vehicle
Sponsors
Pfizer
Conditions
Dermatitis AtopicHealthy
Phase 1
A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants
CompletedNCT04135560
Start: 2019-10-29End: 2020-04-10Updated: 2020-05-14
Study to Evaluate the Safety, Local and Systemic Tolerability, and Pharmacokinetics of Multiple-Dose Topical Administration of PF-07038124 in Japanese Healthy Participants
CompletedNCT04863417
Start: 2021-06-30End: 2021-09-09Updated: 2024-01-25